Immunohistochemical profiling is essential for differentiating PASH from low-grade angiosarcoma, with specific markers such as CD34, vimentin, desmin, actin, and progesterone receptor aiding in the correct diagnosis and preventing misinterpretation. Here, DES is linked to angiosarcoma.